Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05051787Phase 4Completed
Phase 4, open-label, single-arm trial of amoxicillin in streptococcal pharyngitis, urinary tract infection (UTI), otitis media and 2 more, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Concentration-time profile of amoxicillin in milk at Day 0 and Concentration-time profile of amoxicillin in plasma at Day 0. Started Jun 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05051787.